Summary
In this report we describe a patient who, after allogeniec bone marrow transplantation from her HLA-identical sister, developed polyendocrine failure in the form of Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism. This was the result of the transfer of donor lymphoid cells which were activated by allogenic bone marrow transplantation. The full chimerism of the recipient was demonstrated by restriction fragment length polymorphism analysis from nucleated blood cells and fibroblast DNA. During the 9-year follow-up, the donor developed hypothyroidism and signs of pre-Type 1 diabetes. This clinical observation resembles the adoptive transfer of diabetes observed in non-obese-diabetic mice and BB rats and confirms the role of immune processes in the pathogenesis of this disease.
Article PDF
Similar content being viewed by others
References
Eisenbarth GS (1986) Type 1 diabetes mellitus—a chronic autoimmune disease. N Engl J Med 314:1360–1368
Utiger RD (1991) The pathogenesis of autoimmune thyroid disease. New Engl J Med 325:278–279
Thomas ED, Storb R, Clift RA et al. (1975) Bone marrow transplantation. N Engl J Med 292:832–843, 895–902
Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovotch AH (1985) Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 66:1436–1444
Knowlton RG, Brown VA, Braman JC et al. (1986) Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation. Blood 68:378–385
Jeffreys AJ, Wilson V, Thein SL (1985) Hypervariable “minisatellite” regions in human DNA. Nature 314:67–73
Jeffreys AJ, Wilson V, Thein SL (1985) Individual-specific “fingerprints” of human DNA. Nature 316:76–79
Xerri L, Maraninchi D, Bertheas MF, Gaspard MH, Mawas C, Birg F (1989) “Minisatellite” DNA probes detect engraftment and/or chimerism in recipients of HLA-matched bone marrow transplants. Transpl Int 2:53–55
San Marco M, Vialettes B, Maraninchi D, Bernard D (1991) Autoantibody formation after bone marrow transplantation: a comparison between autologous and allogeneic grafts. Autoimmunity 11:7–12
Thivolet C, Tappaz N, Durand A et al. (1992) Glutamic acid decarboxylase (GAD) auto-antibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35:570–576
Vialettes B, Mattei-Zevaco C, Badier C, Ramahandridona G, Lassmann-Vague V, Vague Ph (1988) Low acute insulin response to intravenous glucose. A sensitive but non specific marker of early stages of type 1 diabetes. Diabetologia 31:592–596
Atkinson K (1990) Chronic graft versus host disease. Bone Marrow Transplant 5:69–82
Marmont AM (1992) Autoimmunity and allogeneic bone marrow transplantation. Bone Marrow Transplant 9:1–3
Rouquette-Gally AM, Boyeldieu D, Prost AG, Gluckman E (1988) Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 46:238–240
Holmes JA, Livesey SJ, Bedwell AE, Amos N, Whittaker JA (1989) Auto-antibody analysis in chronic graft-versus-host-disease. Bone Marrow Transplant 4:529–531
Kolb H, Freytag G, Kiesel V, Kolb-Bachofen V (1981) Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease. Clin Exp Immunol 43:121–125
Sale GE, Shulman HM (1984) Pathology of other organ systems. In: Sale GE, Shulman HM (eds) Pathology of bone marrow transplantation. Masson Publishing USA, Inc, New York, pp 190–198
Smith CI, Aarli JA, Biberfeld P et al. (1983) Myasthenia gravis after bone marrow transplantation. Evidence for a donor origin. N Engl J Med 309:1565–1568
Bolger GB, Sullivan KM, Spence AH et al. (1986) Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft versus host disease. Neurol 36:1087–1091
Lefvert A, Björkholm M (1987) Antibodies against the acetylcholine receptor in hematologic disorders: implication for the development of myasthenia gravis after bone marrow transplantation. New Engl J Med 317:170 (Letter)
Grau JM, Casademont J Montforte R (1990) Myasthenia gravis after bone marrow transplantation: report of a new case and pathogenic considerations. Bone Marrow Transplant 5:435–437
Melms A, Faul C, Sommer N, Wiethölter H, Müller CA, Ehninger G (1989) Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 9:78–79
Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ (1989) Graft-v-host disease is associated with autoimmune-like thrombocytemia. Blood 73:1054–1058
Rochet N, Blanche S, Carel JC et al. (1989) Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child. Diabetologia 32: 167–172.
Wyatt DT, Lum L, Caper J, Hunter J, Camitta B (1990) Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 5:357–361
Aldouri MA, Ruggier R, Epstein O, Prentice HG (1990) Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukemia. Br J Haematol 74:118–119
Like AA, Weringer EJ, Holdash A, MacGill P, Atkinson D, Rossini AA (1985) Adoptive transfer of auto-immune diabetes mellitus in biobreeding/Worcester (BB/W) imbred and hybrid rats. J Immunol 134:1583–1587
Wicker LS, Miller BJ, Mullen Y (1986) Transfer of autoimmune diabetes mellitus with splenocytes from non obese diabetic (NOD) mice. Diabetes 35:855–860
Serreze DV, Leiter EH, Shultz LD (1990) Transplantation analysis of B cell destruction in (NOD x CBA) F1 mouse bone marrow chimeras. Diabetologia 33:84–92
McKeever U, Mordes JP, Greiner DL et al. (1990) Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Nat Acad Sci USA 87:7618–7622
Riley WJ, MacLaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167–1172
Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS (1990) Analysis of metabolic progression to type 1 diabetes in ICA + relatives of patients with type 1 diabetes. Diabetes Care 13:111–118
Atkmsan K, Hansen J, Storb R et al. (1982) T cell subpopulation identified by monoclonal antibodies after human marrow transplanation. I Helper-inducer and cytotoxic-suppressor subsets. Blood 59:1292–1298
Warren HS, Atkinson K, Pernbrey RG, Biggs JC (1983) Human bone marrow allografts: production of and responsiveness to interleukin 2. J Immunol 131:1771–1774
Charmot D, Ragueneau M, Olive D, Maraninchi D, Mawas C (1987) Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation. Bone Marrow Transplant: 183–194
Tarn AC, Thomas JM, Dean BM et al. (1988) Predicting insulin-dependent diabetes. Lancet I:845–850
Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab Invest 53:132–146
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vialettes, B., Maraninchi, D., San Marco, M.P. et al. Autoimmune polyendocrine failure — Type 1 (insulin-dependent) diabetes mellitus and hypothyroidism — after allogenic bone marrow transplantation in a patient with lymphoblastic leukaemia. Diabetologia 36, 541–546 (1993). https://doi.org/10.1007/BF02743271
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02743271